Lipocine to present at H.C. Wainwright conference on September 16, 2026

Sep 10, 2026 08:15 (45d ago)

Verifying

Lipocine Inc. announced a presentation at the H.C. Wainwright investment conference.
The event is scheduled for September 16, 2026.
Lipocine develops novel oral therapeutics, including treatments described incompletely in the source.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.